Logo-jnp
J Nephropathol. 2023;12(4): e17238. doi: 10.34172/jnp.2022.17238

Original Article

Platelet glycogen synthase kinase 3β regulates plasma β amyloid and phosphorylated tau levels in chronic kidney disease patients with cognitive dysfunction; therapeutic role of erythropoietin

Vinothkumar Ganesan 1 ORCID, Krishnakumar Sethuraman 2,3 ORCID, Sureshkumar Sureshkumar 4 ORCID, Venkataraman Prabhu 1 * ORCID

Cited by CrossRef: 2

1- Shatalova N, Dzamikhov K, Kochetkov A, Batyukina S, Ebzeyeva E, Ostroumova O. Cognitive function status in polymorbid patients with arterial hypertension, atrial fibrillation and chronic kidney disease. Medicinskij alfavit. 2024;(33):50 [Crossref]
2- Dzamikhov K, Kochetkov A, Ostroumova O, Shastina V, Arablinskiy A, Orlov A, Puzin S. Factors Affecting the Functional Status of Multimorbid Elderly Patients With Essential Hypertension. HERALD of North-Western State Medical University named after II Mechnikov. 2025;17(1):63 [Crossref]
3- Alhassan H, Janiyani K, Surti M, Adnan M, Patel M. The dual role of glycogen synthase kinase-3 beta (GSK3β) in neurodegenerative pathologies: interplay between autophagy and disease progression. Front Pharmacol. 2025;16 [Crossref]
4- Ostroumova O, Dzamikhov K, Kochetkov A, Ostroumova Т, Ebzeyeva E, Andrianov А, Dashabylova V. Anticholinergic burden and the cognitive functions in elderly and senile patients with arterial hypertension. Medicinskij alfavit. 2024;(13):68 [Crossref]